While providing few details about the
snafu, Chiron announced yesterday that the U.K. Medicines and Healthcare Products Regulatory Agency had suspended the company's
license to produce flu vaccine because Chiron does not comply with Good Manufacturing Practices regulations in the United Kingdom.